UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000006804
Receipt No. R000008053
Scientific Title PhaseII trial of capecitabine plus cisplatin in patients with recurrent HER-2 negative gastric cancer during or after the adjuvant chemotherapy using S-1 (T-CORE1102)
Date of disclosure of the study information 2011/12/01
Last modified on 2020/07/07 15:39:28

No. Disposal Last modified on Item of update
1 Insert 2011/11/30 19:30:39
2 Update 2011/11/30 19:32:29 Public title
Acronym
3 Update 2012/01/04 20:36:27 Recruitment status
4 Update 2014/12/01 12:14:26 Interventions/Control_1
5 Update 2014/12/01 12:15:47 Email
6 Update 2015/06/01 15:10:58 Last name of contact person
Last name of contact person
7 Update 2016/01/05 09:23:53 Email
8 Update 2017/06/05 08:47:10 Recruitment status
9 Update 2018/06/05 10:53:09 Last name of contact person
Last name of contact person
Name of person sending information
Email
Name of primary sponsor
Institute
Organization
Organization
10 Update 2019/02/18 13:54:21 Last name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Organization1
Address1
Tel1
Email1
11 Update 2020/07/07 15:35:02 Date of IRB
12 Update 2020/07/07 15:35:26 Recruitment status
13 Update 2020/07/07 15:36:59 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
14 Update 2020/07/07 15:39:06 Last follow-up date
15 Update 2020/07/07 15:39:28 Number of participants that the trial has enrolled


Contact us.